Trials / Completed
CompletedNCT02548845
An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain
An Observational, Retrospective Study to Describe the Extent of Adherence to the Spanish Society of Medical Oncology Algorithm for the Treatment of Hyponatraemia Secondary to SIADH in Oncology Patients in Spain (ALGA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Otsuka Pharmaceutical Europe Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In 2014, the Spanish Sociedad Española de Oncología Médica (SEOM) algorithm for the treatment of hyponatraemia secondary to to syndrome of inappropriate antidiuretic hormone (SIADH) in oncology patients was developed. Since it is hypothesised that the adherence to the SEOM algorithm is not 100%, the current retrospective non-interventional study will investigate the perceived and actual adherence of participating centres to the SEOM algorithm and its impact on patient outcomes
Conditions
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-09-14
- Last updated
- 2018-08-06
- Results posted
- 2018-08-06
Locations
4 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02548845. Inclusion in this directory is not an endorsement.